Official websites use .gov
Secure .gov websites use HTTPS
« Previous
Next »
Titles
- CMS should bolster its oversight of manufacturer-submitted average sales price data to ensure accurate Part B drug payments1
- How much are Medicare beneficiaries paying out-of-pocket for prescription drugs?1
- Manufacturers may need additional guidance to ensure consistent calculations of average sales prices1
- Medicare Part B drug payments: impact of price substitutions based on 2021 average sales prices1
- Medicare Part D: CMS should monitor effects of rebates on plan formularies and beneficiary spending : report to congressional requesters1
- Three states' approaches to pharmaceutical assistance: a guide for the perplexed1